ABCC1 and neoplasm: ABCC1 also recognizes and transports some of the newer “targeted” anticancer agents that modify pathway components controlling tumor growth, proliferation, and metastatic potential, such as tyrosine kinase inhibitors (Brózik et al., 2011; Cole, 2014b).